Ganciclovir
Products in Health Canada’s databases that list Ganciclovir as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 4
- 1 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 13
- Products in all
- 4
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| EYEZIRGAN (0.15 %) | 02530546 | Marketed | Laboratoires Théa | |
| CYTOVENE - CAP 250MG (250 MG) | 02186802 | Cancelled Post Market | Hoffmann-La Roche Limited | |
| CYTOVENE, 500 MG (500 MG) | 02240362 | Cancelled Post Market | Hoffmann-La Roche Limited | |
| VITRASERT, INTRAVITREAL IMPLANT (4.5 MG) | 02233015 | Cancelled Post Market | Bausch & Lomb Inc. |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- EYEZIRGANJune 5, 2024 · NOC 33395
- GANCICLOVIR FOR INJECTION USPJune 16, 2023 · NOC 31007
- EYEZIRGANSeptember 8, 2022 · NOC 28910
- GANCICLOVIR FOR INJECTION USPJanuary 17, 2018 · NOC 20360
- CYTOVENEJune 30, 2017 · NOC 19478
- GANCICLOVIR FOR INJECTION USPApril 10, 2013 · NOC 14273
- CYTOVENEMay 1, 2008 · NOC 9535
- VITRASERTJanuary 19, 2005 · NOC 6210
- CYTOVENEJuly 2, 1999 · NOC 1834
- VITRASERTJanuary 14, 1999 · NOC 2057
- VITRASERTSeptember 4, 1997 · NOC 3827
- CYTOVENEJuly 28, 1997 · NOC 3826
- CYTOVENEOctober 10, 1995 · NOC 5033